放射科医生需了解的RAS病
RAS病是一组由Ras/MAPK信号通路基因胚系突变引起的异质性遗传综合征,包括神经纤维瘤病1型、Legius综合征、Noonan综合征、Costello综合征、心面皮肤综合征、中枢传导淋巴管异常和毛细血管畸形-动静脉畸形综合征。这些疾病罕见但合计为最常见的遗传病(每1000名新生儿中1例),临床表现和影像特征既有重叠又多样。本文介绍主要代表性RAS病,重点阐述其影像学相似性与差异,以帮助放射科医生参与多学科诊疗。
要点
- RAS病包括神经纤维瘤病1型、Legius综合征、Noonan综合征、Costello综合征、心面皮肤综合征、中枢传导淋巴管异常和毛细血管畸形-动静脉畸形综合征。
- RAS病由Ras/MAPK通路异常激活所致,累及心血管、淋巴、肌肉骨骼、皮肤和中枢神经系统,影像表现重叠且多样。
- 某些RAS病与良性和恶性肿瘤相关,放射科医生需认识RAS病概念以参与多学科诊疗。
核心结论
- RAS病是一组由Ras/MAPK通路胚系突变引起的异质性遗传综合征,影像特征既有重叠又多样,放射科医生应认识该概念以参与多学科诊疗。
研究设计与样本
- 本文为综述,介绍主要代表性RAS病并重点阐述其影像学相似性与差异,未报告系统检索范围与纳入文献数量。
临床应用与阅片要点
- 放射科医生需认识RAS病的概念,以参与RAS病多学科门诊的诊疗。
- RAS病的影像特征与临床表现一样,既有重叠又多样,阅片时需注意各综合征之间的相似性与差异。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RASopathies are a heterogeneous group of genetic syndromes caused by germline mutations in a group of genes that encode components or regulators of the Ras/mitogen-activated protein kinase (MAPK) signaling pathway. RASopathies include neurofibromatosis type 1, Legius syndrome, Noonan syndrome, Costello syndrome, cardiofaciocutaneous syndrome, central conducting lymphatic anomaly, and capillary malformation-arteriovenous malformation syndrome. These disorders are grouped together as RASopathies based on our current understanding of the Ras/MAPK pathway. Abnormal activation of the Ras/MAPK pathway plays a major role in development of RASopathies. The individual disorders of RASopathies are rare, but collectively they are the most common genetic condition (one in 1000 newborns). Activation or dysregulation of the common Ras/MAPK pathway gives rise to overlapping clinical features of RASopathies, involving the cardiovascular, lymphatic, musculoskeletal, cutaneous, and central nervous systems. At the same time, there is much phenotypic variability in this group of disorders. Benign and malignant tumors are associated with certain disorders. Recently, many institutions have established multidisciplinary RASopathy clinics to address unique therapeutic challenges for patients with RASopathies. Medications developed for Ras/MAPK pathway-related cancer treatment may also control the clinical symptoms due to an abnormal Ras/MAPK pathway in RASopathies. Therefore, radiologists need to be aware of the concept of RASopathies to participate in multidisciplinary care. As with the clinical manifestations, imaging features of RASopathies are overlapping and at the same time diverse. As an introduction to the concept of RASopathies, the authors present major representative RASopathies, with emphasis on their imaging similarities and differences. ©RSNA, 2024 Test Your Knowledge questions for this article are available in the supplemental material.
引用
- Handa A, Tsujioka Y, Nishimura G, et al. RASopathies for Radiologists. Radiographics. 2024. PMID: 38602868. doi:10.1148/rg.230153
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。